share_log

Reviewing Pro-Dex (NASDAQ:PDEX) & ICU Medical (NASDAQ:ICUI)

Reviewing Pro-Dex (NASDAQ:PDEX) & ICU Medical (NASDAQ:ICUI)

审查 Pro-Dex(纳斯达克股票代码:PDEX)和 ICU Medical(纳斯达克股票代码:ICUI)
Defense World ·  2022/12/16 01:51

Pro-Dex (NASDAQ:PDEX – Get Rating) and ICU Medical (NASDAQ:ICUI – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

亲德克斯(纳斯达克:PDEX-GET评级)和ICU医疗(纳斯达克:ICUI-GET评级)都是医疗公司,但哪只股票更好?我们将根据这两家公司的盈利能力、机构所有权、收益、风险、估值、股息和分析师建议来比较它们的实力。

Volatility & Risk

波动性与风险

Pro-Dex has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500.

Pro-Dex的贝塔系数为0.91,表明其股价的波动性比标准普尔500指数低9%。相比之下,ICU Medical的贝塔系数为0.54,表明其股价的波动性比标准普尔500指数低46%。

Get
到达
Pro-Dex
支持Dex
alerts:
警报:

Institutional & Insider Ownership

机构与内部人持股

13.7% of Pro-Dex shares are held by institutional investors. Comparatively, 90.2% of ICU Medical shares are held by institutional investors. 42.6% of Pro-Dex shares are held by company insiders. Comparatively, 7.3% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

机构投资者持有Pro-Dex公司13.7%的股份。相比之下,ICU Medical 90.2%的股份由机构投资者持有。42.6%的Pro-Dex股票由公司内部人士持有。相比之下,ICU医疗7.3%的股份由公司内部人士持有。强大的机构持股表明,捐赠基金、大型基金管理公司和对冲基金相信,一只股票有望实现长期增长。

Analyst Recommendations

分析师建议

This is a breakdown of current recommendations and price targets for Pro-Dex and ICU Medical, as reported by MarketBeat.
据MarketBeat报道,这是Pro-Dex和ICU Medical目前的建议和价格目标的细目。
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex 0 0 0 0 N/A
ICU Medical 0 1 1 0 2.50
销售评级 保持评级 购买评级 强劲的买入评级 评级分数
支持Dex 0 0 0 0 不适用
ICU医疗 0 1 1 0 2.50

Pro-Dex currently has a consensus price target of $30.00, indicating a potential upside of 72.52%. ICU Medical has a consensus price target of $195.00, indicating a potential upside of 23.29%. Given Pro-Dex's higher possible upside, equities research analysts plainly believe Pro-Dex is more favorable than ICU Medical.

Pro-Dex目前的共识目标价为30.00美元,表明潜在上行空间为72.52%。ICU Medical的共识目标价为195.00美元,表明潜在涨幅为23.29%。考虑到Pro-Dex的更高可能上行空间,股票研究分析师显然认为Pro-Dex比ICU Medical更有利。

Earnings and Valuation

收益和估值

This table compares Pro-Dex and ICU Medical's revenue, earnings per share and valuation.

此表比较了Pro-Dex和ICU Medical的收入、每股收益和估值。

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pro-Dex $42.04 million 1.48 $3.86 million $1.04 16.72
ICU Medical $1.32 billion 2.88 $103.14 million ($1.56) -101.39
总收入 价格/销售额比 净收入 每股收益 市盈率
支持Dex 4,204万美元 1.48 386万美元 $1.04 16.72
ICU医疗 13.2亿美元 2.88 1.0314亿美元 ($1.56) -101.39

ICU Medical has higher revenue and earnings than Pro-Dex. ICU Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

ICU Medical的收入和收益比Pro-Dex更高。ICU Medical的市盈率低于Pro-Dex,表明它目前是两只股票中更负担得起的一只。

Profitability

盈利能力

This table compares Pro-Dex and ICU Medical's net margins, return on equity and return on assets.

此表比较了Pro-Dex和ICU Medical的净利润率、股本回报率和资产回报率。

Net Margins Return on Equity Return on Assets
Pro-Dex 8.97% 16.75% 8.53%
ICU Medical -1.90% 6.51% 3.28%
净利润率 股本回报率 资产回报率
支持Dex 8.97% 16.75% 8.53%
ICU医疗 -1.90% 6.51% 3.28%

Summary

摘要

Pro-Dex beats ICU Medical on 8 of the 13 factors compared between the two stocks.

在两只股票之间进行比较的13个因素中,有8个是Pro-Dex击败了ICU Medical。

About Pro-Dex

关于Pro-Dex

(Get Rating)

(获取评级)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Pro-Dex公司为世界各地的医疗器械原始设备制造商设计、开发、制造和销售动力手术器械。该公司提供可高压灭菌、电池供电和电动的多功能外科驱动程序和剃须刀,主要用于整形外科、胸部和颅颌面部市场。它还提供工程、质量和监管咨询服务;并向各种行业制造和销售旋转空气马达。该公司成立于1978年,总部设在加利福尼亚州欧文。

About ICU Medical

关于ICU医疗

(Get Rating)

(获取评级)

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICU医疗公司及其子公司在全球范围内开发、制造和销售用于输液治疗和危重护理应用的医疗设备。该公司的输液治疗产品包括MicroClave、MicroClave Clear和NanoClave品牌的无针产品;中子导管通畅设备;SwabCap和SwabTip消毒帽;Tego血液透析连接器;ClearGuard HD,血液透析导管的抗菌屏障帽;ChemoClave和ChemoLock封闭式系统传输设备,以及用于制备危险药物的Diana危险药物复合系统。它还提供静脉治疗和稀释剂,如氯化钠、葡萄糖、平衡电解质溶液、乳酸林格氏症、林格氏症、甘露醇、氯化钠/葡萄糖和无菌水;灌溉包括氯化钠和无菌水灌溉、生理溶液、林格氏灌溉、醋酸灌溉、甘氨酸灌溉、山梨醇-甘露醇灌溉、弹性容器和灌装瓶选项。该公司提供Plum 360和LifeCare PCA品牌的输液泵;IV中介安全软件,包括ICU Medical MedNet,这是一个企业级药物管理平台,将智能泵连接到医院的电子健康记录、资产跟踪系统和警报通知平台;以及相关专业服务。该公司还提供重症监护产品,如Cogent二合一和心脏Flo血流动力学监测系统;TDQ和OptiQ心输出量监测导管;TriOx静脉血氧仪导管;TRANSPAC血压传感器;以及SafeSet封闭式血液采样和保存系统。该公司将其产品销售给急性护理医院、批发商、门诊诊所和备用场所设施,包括门诊诊所、家庭保健提供者和长期护理设施。ICU医疗, 公司成立于1984年,总部设在加利福尼亚州圣克莱门特。

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.

接受Pro-Dex Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Pro-Dex和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发